Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries IM Cannabis Corp (CSE: IMCC ) 2.940 UNCHANGED Official Closing Price Updated: 1:52 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about IM Cannabis Corp < Previous 1 2 Next > IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY August 14, 2024 The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023.... Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now August 06, 2024 Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,... Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know July 05, 2024 IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares. Via Benzinga Topics Cannabis Exposures Cannabis Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany June 05, 2024 Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:... Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue May 08, 2024 IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter... Via Benzinga Topics Cannabis Exposures Cannabis Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC April 04, 2024 Via ACCESSWIRE IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity March 28, 2024 IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on... Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability' August 14, 2023 IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Tuesday for the period ending June 30, 2023. Via Benzinga Topics Cannabis Exposures Cannabis Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel October 12, 2022 Via ACCESSWIRE IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel January 19, 2022 The successful import demonstrates the strength of the IM Cannabis global supply chain and business model TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the... From IM Cannabis Corp. Via AccessWire Topics Cannabis Economy Exposures Cannabis Supply Chain IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary January 13, 2022 Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp.... From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures Cannabis IM Cannabis to Launch WAGNERS Brand in Germany December 07, 2021 IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market TORONTO, ON, GLIL YAM, ISRAEL and BAD OLDESLOE, GERMANY / ACCESSWIRE... From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures COVID-19 Cannabis IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock December 01, 2021 IM Cannabis Corp. (CSE:IMCC), (NASDAQ: Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy December 01, 2021 Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million Oranim's trailing 12-month... From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures Cannabis IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval November 30, 2021 IM Cannabis Corp. (CSE:IMCC) (NASDAQ: Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel November 29, 2021 IM Cannabis' popular recreational cannabis brand WAGNERS will be available in Israel in 2022, enhancing IM Cannabis' presence in the market TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 29,... From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures COVID-19 Cannabis IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction November 18, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update November 15, 2021 Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022 Canadian recreational brands WAGNERS... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction October 20, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 20, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IMC Provides Further Details on Panaxia Transaction September 08, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use... From IM Cannabis Corp. Via AccessWire Topics Cannabis Intellectual Property Law Enforcement Exposures COVID-19 Cannabis Intellectual Property IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel August 16, 2021 Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021 Acquisition of Vironna pharmacy positions IMC in rapidly growing Arab consumer segment in Israel Following strong start to Q3 across each... From IM Cannabis Corp. Via AccessWire Topics Cannabis Intellectual Property Law Enforcement Exposures COVID-19 Cannabis Intellectual Property IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction August 09, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IMC Announces Results of its Annual General and Special Meeting of Shareholders August 03, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use... From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures Cannabis IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way July 28, 2021 - Strategically located, best in class retailer with approximately CAD$8 million in annualized revenue - Purchase price of CAD$4.6 million TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July... From IM Cannabis Corp. Via AccessWire Topics Cannabis Intellectual Property Law Enforcement Exposures COVID-19 Cannabis Intellectual Property IM Cannabis Provides Update on German Operations and Financial Outlook July 23, 2021 TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IM Cannabis Provides Business, Legal and Regulatory Update July 13, 2021 - IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCo - German Brand Institute awards IMC with the... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IM Cannabis Closes Acquisition of MYM Nutraceuticals July 09, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal MYM Shareholders Overwhelmingly Approve Plan of Arrangement with IM Cannabis July 06, 2021 Highland Grow is currently profitable on an EBITDA basis, unlocks margin expansion and is expected to be immediately accretive to IM Cannabis Super premium positioning, complementary brands, enhanced... From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IM Cannabis Proposed Acquisition of MYM Receives Positive Recommendations from Proxy Advisory Firms Glass Lewis and ISS June 28, 2021 Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC Over 90% of committed and tallied common shares are being voted in favor of the... From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures COVID-19 Cannabis IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions June 17, 2021 Conditions Evaluated Include Oncology, PTSD, Rheumatoid Arthritis, Chronic Pain, Insomnia, Back Pain and Inflammatory Bowel Diseases Conducted by Leading Contract Research Organization for Cannabis... From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures Cannabis Product Safety < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.